Jakub Zolnierek Selected Research

Drug Therapy (Chemotherapy)

2/2013

New therapeutic options in systemic treatment of advanced cutaneous melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jakub Zolnierek Research Topics

Disease

4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2009
2	Neoplasms (Cancer) 01/2021 - 01/2009
1	Microsatellite Instability 12/2023
1	Colorectal Neoplasms (Colorectal Cancer) 12/2023
1	Carcinoma (Carcinomatosis) 09/2023
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Disease Progression 11/2015
1	Proteinuria 11/2015
1	Myocardial Infarction 11/2015
1	Hypertension (High Blood Pressure) 03/2014
1	Clear-cell metastatic renal cell carcinoma 03/2014
1	Fatigue 03/2014
1	Melanoma (Melanoma, Malignant) 02/2013

Drug/Important Bio-Agent (IBA)

2	pembrolizumabIBA 12/2023 - 09/2023
2	lenvatinibIBA 09/2023 - 11/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 03/2014
2	Sorafenib (BAY 43-9006)FDA Link 03/2014 - 01/2009
1	Immune Checkpoint InhibitorsIBA 12/2023
1	PlatinumIBA 09/2023
1	Pyruvate KinaseIBA 01/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021
1	Fructose-BisphosphataseIBA 01/2021
1	Everolimus FDA Link 11/2015
1	MTOR InhibitorsIBA 03/2014
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 03/2014
1	Phosphotransferases (Kinase)IBA 02/2013
1	Immunomodulating AgentsIBA 02/2013
1	Sunitinib (Sutent)FDA Link 01/2009
1	Tyrosine Kinase InhibitorsIBA 01/2009

Therapy/Procedure

4	Therapeutics 09/2023 - 01/2009
1	Drug Therapy (Chemotherapy) 02/2013
1	Immunotherapy 02/2013